Keros Therapeutics

Keros Therapeutics

KROS· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +28.6% in FY2025

Jasbir Seehra, Ph.D. is the CEO of Keros Therapeutics and was paid $2.5M in FY2025 (Dec), down 60%.

Pay$100 in the stock at the end of FY20 → $29
CEO pay is from each Keros Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1Christopher RovaldiFY2024
  2. 2Jasbir Seehra, Ph.D.FY2025
  3. 3Keith RegnanteFY2025
  4. 4Esther Cho, Esq.FY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Keros Therapeutics paid its 3 named executives $4.8M in total in FY2025 (Dec). CEO Jasbir Seehra, Ph.D. was paid $2.5M of that.

Name
Jasbir Seehra, Ph.D.President and Chief Executive Officer
Keith RegnanteChief Financial Officer
Esther Cho, Esq.Chief Legal OfficerNot disclosedNot disclosed
Christopher RovaldiFormer President and Chief Operating OfficerNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers19

See all

The FY2025 (Dec) proxy of Keros Therapeutics names 19 peer companies for pay. Among Keros Therapeutics and these peers, CEO pay was the lowest of 8 and total shareholder return was 7th highest of 8.

8th highest of 8in Keros Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:

$2.5M$33.3M

7th highest of 8in Keros Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:

$20$487

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board4

See all
  • Jean-Jacques BienaiméLead independent director · 0 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive
  • Carl L. GordonDirector · 4 yr on the boardIndependentCompensation—Paid as an executive
  • Nima FarzanDirector · 4 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive
  • Tomer KarivDirector · 4 yr on the boardIndependentNominating and Corporate Governance (Chair)—Paid as an executive

The board of the latest proxy (FY2024).

Activity

  1. PayDEF 14A
  2. PayDEF 14A
  3. PayDEF 14A
  4. PayDEF 14A
  5. Board3
  6. PayDEF 14A
  7. PayDEF 14A
  8. PayDEF 14A
  9. Board3

Filings6

See all
Proxy statementDEF 14AApr 22, 2026FY2025
Annual report10-KMar 4, 2026FY2025
Proxy statementDEF 14AApr 23, 2025FY2024
Annual report10-KFeb 26, 2025FY2024
Proxy statementDEF 14AApr 17, 2024FY2023
Annual report10-KFeb 28, 2024FY2023